Mastocytosis is a rare disease that causes its victims pains in the body, anaphylactic shocks and in some cases death. There is currently no cure for this disease but there are some medications taken to manage the symptoms of this disease. The cause of mastocytosis is the overabundance of mast cells in the blood stream, body tissues, and bone marrow. These mast cells are well meaning hematopoietic cells which are members of the body's response to an allergy. It has been established that tetracyclines possess anti-bacterial properties, but recent development has also shown that it also possesses anti-inflammatory properties as well as apoptotic properties which can be applied in the treatment of mastocytosis. This paper focuses on the use of the principle of "Creative synthesis" to formulate a possible treatment to mastocytosis using tetracycline and polyphenols as well as chemically modified tetracyclines (CMTs). In addition, investigations will be carried out to proffer a possible combination which will help in inhibiting the effects of mastocytosis. Based on the synthesis, an economic analysis will be carried out to show the economic potential of this proffered treatment.
Introduction
As much as the cells perform a well-meaning agenda within the body by responding to foreign allergens, it is also reported to function in manners that lead from an annoying to catastrophic reactions and possibly contribute to the pathology of autoimmune diseases [1] .
The term mast cell activation disease represents a stack of disorders described In most patients, the cause of the disease is from the activating mutation (D816V) in the gene coding for the stem cell factor receptor c-kit, which is present on mast cells. The resulting effect is the auto phosphorylation of the receptor, which is responsible for uncontrolled mast cell proliferation. Mast cell activation disease is currently recognized to likely be significantly pervasive and along these lines ought to be considered routinely in the differential diagnosis of patients with incessant multisystem polymorbidity or patients in whom an absolutely diagnosed major ailment does not well account for the totality of the patient's presentation. This research looks into creative ways of inhibiting the uncontrolled release of bioactive mediators into the body responsible for causing mastocytosis with the polyphenol tetracycline. This method used is creative synthesis and associative thinking. I am taking an out of the box thinking about mast cells and the possibility of using tetracycline for the treatment of mastocytosis.
Technical Background
The process of hematopoiesis has to do with the differentiation of multipotent cells into blood and immune cells. These multipotent hematopoietic stem cells give rise to many different cell types which include the cells of the immune system and that of the red blood cells, as seen in Figure 1 [3] [4] .
Mast cells are immune cells of hematopoietic source found in every single human tissue, particularly at the environmental interfaces. They go about as both effector and coordinator cells and assume a focal part in modifying and intrinsic immunity [6] [7] . Their critical part in immunological and also non-immunological procedures is reflected by the extensive number of mediators (>200) including pre-stored ones, for example, histamine and tryptase and in addition numerous mediators that are resynthesized as a response to the non-immune or allergic triggers, for example, chemokines and cytokines, through which the mast cells may impact other different cells [8] . Their developed multitudes of sensory and response systems induce different chaos when mast cells defect develops. Figure 1 . Image of hematopoietic stem cell breakdown [5] .
The mast cell is a one of a kind effector part of the immune system described by the existence of metachromatically staining secretory granules, surface expression of the high affinity of IgE receptor (FcεRI) , and localization at tissue sites which are adjacent to the microvasculature and at mucosal and epithelial surfaces [9] . The basophils, eosinophils, neutrophils, platelets, macrophages, and certain subsets of lymphocytes additionally contain secretory granules ( Figure   2 ); yet of these granulated cells just the mast cell and basophil express FceRI.
FcεRI expression was once thought-out as exclusively for mast cells and basophils, yet two groups have now given solid confirmation that the epidermal langerhans' cell transcribes and expresses the entire tetrameric FcεRI molecule on the surface [10] . It has also been discussed that the FcεRI presence on mast cells and basophils empowers these two cells to be actuated by the adhering of the IgE to FcεRI and resulting cross-linking when a particular antigen is encountered.
The acknowledgment that mast cells discharge an extensive variety of proinflammatory, immunomodulatory, and mitogenic cytokines, mediators that are lipid-derived, and nonpartisan proteases and also the exhibition of functional surface IgG receptors on these cells propose that mast cells most likely assume a more central part in immune and inflammatory processes than those customarily considered. The creation of immunomodulatory cytokines, for example, interleukin-4 (IL-4), by mast cells which can prompt T-helper cell differentiation, is one case of how mast cells may work as regulators and additionally effector components of the immune response as observed in Figure 3 . Mast cell-microorganism interactions. Microorganisms such as bacteria or parasites or their products interact with mast cells through specific receptors. This interaction results in mast cell activation and mediator release which elicit an inflammatory response or direct killing leading to bacterial clearance [11] .
there will be more proliferation, differentiation, and maturation can happen in light of tissue and organ specific factors [9] . Conversely, basophils develop completely in the bone marrow and are terminally differentiated, the short-lived members from the blood granulocyte compartment where they react to inflammatory mediators by endothelial cell adhesion, extravascular migration, chemotaxis, and activation at the sites of particular inflammation [9] . A lot of recent observations demonstrate that they may likewise have a key part in organizing the early phases of immune system illnesses, especially those including auto-antibodies [12] .
bioactive mediators from secretory granules, the biosynthesis and discharge of recently formed mediators gotten from arachidonic acid, and a wide panel of cytokines that are synthesized or secreted, as seen in Figure 5 [9].
The monomeric IgE binding to FcεRI as such is thought not to bother the receptor or to bring about cellular events. The gathering of FcεRI by resulting binding of multivalent antigen triggers mast cell activation. The earliest perceived event is phosphorylation of particular substrates, including autophophorylation of the β and γ subunits and phospholipase Cγl (PLCγl) [14] [15] by means of tyrosine kinase activity, which copurifies with IgE receptor complexes. Three kinases p56lyn, pp60c-src, and p62c-yes are activated after FcεRI is cross-linked [16] . In addition, it appears that in any event some of these tyrosine kinases closely correlate with FcεRI and are in charge of the initial phosphorylation of PLCγl, potentially through interaction with a conserved motif in the cytoplasmic part of the FcεRI-B and FcεRI-γ chains [17] . The activation of PLCγl constitutes one early transduction pathway; a second pathway includes tyrosine phosphorylation of a 72-kd substrate known as pp72. The resulting events in the pp72 pathway are obscure [18] . The development in intracellular calcium starts activation of calmodulin-dependent pathways, including the phosphatase calcineurin. Calcineurin possibly controls the activity of various transcription factors that are imperative to cytokine gene expression in T lymphocytes [19] and mast cells [20] . . Mast cells in development of allergy [13] .
secretory granule middle people and deciphered and deciphered mast cell cytokines. Table 1 shows different mast cell mediators.
Roles of Mast Cells in Acute Inflammation
Various research in mast cell-deficient and reconstituted mice have exhibited that mast cells in particular, though restricted, models of inflammation enhances many characteristics of immunologically non-specific acute inflammatory responses [11] . These reactions are indicated by an influx of leukocytes (mostly neutrophils), edema, and changes in the caliber and permeability of the micro- 
Mastocytosis
Mastocytosis is a moderately uncommon disease portrayed pathologically by mast cell hyperplasia in the skin and other organ, for example, the gastrointestinal tract, bone marrow, lymph nodes, liver, and spleen. Some of the medical Mast cell-derived cytokines Proinflammatory Cytokines
Mitogenic cytokines and/or growth factors
Immunodulatory cytokines
• IL-1a and IL-1b
• IFN-y symptoms observed with this condition includes, but not limited to, urtication, abdominal pain, pruritus, nausea, vomiting, headache, flushing, diarrhea, and vascular instability. Urticaria pigmentosa, the most well-known skin sign of mastocytosis (shown in Figure 6 ), was depicted by Nettle-transport in 1869 [24] .
Over the top quantities of mast cells were identified in the lesions of urticaria pigmentosa by Unna in 1887 (Unna, 1983). In 1949, Ellis [25] detailed the instance of a child with urticaria pigmentosa with the first posthumous evidence implying that mast cell hyperplasia in skin could be related to systemic disease.
From that point forward, there has been an increase in acknowledgment of the clinicopathologic diversity of mastocytosis [26] . These improvements have been accompanied by a quick expansion in learning of the development, differentiation, and biologic expression of mast cells, including the recognition of the inception of mast cells from CD34+ human pluripotent cells [26] , the description of the growth factor of mast cell which includes interleukin (IL)-3 [27] as well as the c-kit ligand or stem cell factor (SCF) [28] , and the depiction of various pleomorphic and redundant mast cell-derived mediators as shown in Figure 7 [11]. Figure 6 . Urticaria pigmentosa lesions on a child [29] . Figure 7 . admixture of perivenular lymphocytes and scattered eosinophils [30] .
It is unknown the extent to how prevalent mastocytosis currently is, it has been accounted for to be the diagnosed in 1 patient for each 1000 to 2500 new cases found in a dermatology practice or dermatology clinic [31] Mastocytosis can happen at any age and exhibits a slight male-to female predominance. Rare instances of familial mastocytosis have also been reported [32] .
Classification
The characterization has been refined by the National Institute of Health by including a group of patients who were named as having lymphadenopathy mastocytosis with eosinophilia [33] . Such patients show, as the term implies, However, in categories II through IV, urticaria pigmentosa or diffuse cutaneous mastocytosis is a variable finding. It was additionally seen that patients with mastocytosis that is developing into a leukemic procedure may encounter lost urticaria pigmentosa, should it be present [26] . Figure 8 shows a concept map of the classification of mastocytosis.
Tetracycline
In addition to the antibiotic properties of tetracycline, they have also been discovered to exert a number of pleiotropic anti-inflammatory and immunomodulatory activities These include the capacity to inhibit metalloproteinases (MP), which are an enzyme class involved in important cell functions, for example, the shedding of dissolvable mediators and their receptors from the cell surface, and connection with, the remodeling of the extracellular matrix. It was additionally detailed that doxycycline (DOXY) at therapeutic concentrations (1 -5 ug/ml)
suppresses Ig secretion to a significant extent and class switching by in vitro activated murine B cells [35] .
Although the complex chemistry of the tetracyclines is beyond the scope of this thesis, in order to appreciate their ability to interact with a wide variety of biomolecules, a simple knowledge of the main features of these compounds is important to. Tetracyclines, such as DOX, and minocycline (MIN), all possess a four-ring core that is attachedat various side groups ( Figure 9 ). The dimethylamino group, which is located at the C 4 carbon on the upper half of the molecule, . Chemical structure of tetracyclines [36] .
has shown to be of major importance to their characteristic antimicrobial activity.
Chemically modified tetracyclines (CMTs) also known as 4-De-dimethylamino tetracyclines lack antimicrobial activities in vivo and this may be due to the inability of the molecule to adapt the zwitterionic form that will be necessary for activity [37] . In any case, CMTs do hold the capacity to bind other non-microbial targets, for example, matrix metalloproteinases (MMPs), encouraging their utilization in the treatment of other disease processes [37] . The oxygen-rich lower half of the molecule is very important for binding to both prokaryotic and eukaryotic targets, and obstruction with this area decreases or disposes of the potency of the drug [38] . This region is applicable as a site for the metal ion chelation.
The binding of tetracycline to proteins, including the Tet Repressor protein (TetR), might be enormously improved when the tetracycline is complexed with divalent metal ions, for example, Ca 2+ or Mg 2+ [39] . The binding of tetracycline to MMPs is believed to be intervened by the chelation of structural and catalytic 
Matrix Metalloproteinase Inhibition by Tetracyclines
One of the best characterized non-antimicrobial characteristics of the tetracyc- 
Reactive Oxygen Species
There is an excess production of reactive oxygen species under many pathological conditions, for example, myocardial I-R injury and inflammatory processes which can further lead to the oxidative destruction or the dysfunction of many cellular parts. Reactive oxygen species (ROS) have been said to be highly reactive and consist of free radicals superoxide (O 2 ) and hydroxyl radical (OH), the non-free radicals hydrogen perioxide (H 2 O 2 ), hypochloride (HOCl), and peroxynitrate (ONOO − ) [47] . Both DOX and MIN have a multiple-substituted phenol ring similar to vitamin E which is the major key to the ROS-scavenging ability of these compounds. The phenol ring reacts with a free radical to create a more stable and unreactive phenolic radical. It is said that MIN has a more superior scavenging ability and this can be due to the presence of diethyamino group on the phenolic carbon which is exclusive to MIN and it provides the improved steric hindrance [48] .
Proapoptotic Properties of Tetracyclines
In a study completed to observe the cytotoxic impact of Tetracycline Analogs the TCNAs. An IC50 of 1.3 µg/ml was reported, which shows higher sensitivity of the cells to the tetracycline derivative COL-3 than to DOXY and MINO, which was reported to have an IC50 of 9.2 and 9.9 µg/ml, respectively These IC50s are in the low scope of sensitivities detailed in cancer cell lines. IC50 in the range of 3 -10 µg/ml was reported for COL-3, and 10 -20 µg/ml for DOXY [49] [50]. MINO has been reported to repress proliferation of epithelial cancer cell lines with IC50 levels of around 60 µmol/L that compare to 27 µg/ml [51] .
The inhibitory impact of DOXY and COL-3 in HL-60 cells was reported by
Tolemeo et al. [52] . They reported the IC50s for DOXY and COL-3 to be 8 µg/ml and 7 µg/ml, respectively. The results for DOXY were found to be in concurrence with the study, however the IC50 for COL-3 was lower in the study.
This distinction in IC50 can be clarified by various tests and incubation time utilized in the study. The feasibility with resazurin tests was examined, and along these lines analyzed the effects of TCNAs on the metabolic activity of cell mass, while Tolemeo et al. assessed the individual cell viability utilizing trypan blue exclusion assay. They likewise reported AC50 (condition that is able to induce 50% apoptosis) for DOXY and COL-3 to be 15 and 16 µg/ml, respectively, although they didn't examine the underlying apoptotic mechanisms. In the study carried out, COL-3 in a concentration of 5 µg/ml prompted cell death in HL-60 cells.
Other studies that have been published have indicated significant apoptotic and growth inhibitory effects of COL-3 out of a grouping of 10 µg/ml in a wide scope of human tumor cell lines and xenografts [53] [54] [55] . TCNAs have been reported to induce apoptosis in different disease cells; be that as it may, the reported biochemical events that underlies the TCNAs-induced cell death differs [56] [57]. The mitochondrion produces energy for a cell and furthermore controls cell death by releasing factors that promote cell death into the cytosol.
Polyphenols
Polyphenols are an anatomical class of mostly natural (Figure 12 ), yet synthetic [63] . Similarly, the anti-allergy activity of polydatin, a resveratrol glucoside, fundamentally diminished FcεRI-mediated degranulation in IgE-sharpened RBL-2H3 cells in a dose dependent way (1 -100 μM) and repressed the IgE-dependent PCA response in mice (300 mg·kg −1 [64] . Curcumin Table 2 . Naturally occurring mast cell stabilizers [61] . 
Methodology
The method used to obtain results for this thesis is the utilization of associative thinking and creative synthesis from available literature that seem unconnected to develop a new solution for the treatment of mastocytosis.
Creative Synthesis
Creative synthesis is a modern solution for solving existing problems and expanding knowledge. The process of creative synthesis is driven by an innovative drive to solve complex problems in fundamental science and engineering for the purpose or getting novel solutions.
Creative synthesis acts like a guide that prompts advancement of thoughts that are results of the synthesis and can be linked with meta-analysis which is essentially consolidating data from various resources and relating the varied factor. In this instance, tetracycline and tetracycline derived compounds is observed for its inhibitory effect on the production of cytokines such as TNA-a which causes inflammation in mastocytosis.
Creative synthesis recognizes and establishes a complex link between previously unrelated concepts. It is not a particular idea; it is more of a new way to understand what an idea is. Synthesis can be characterized as creative because the new pattern involved in it is a novel construction which is distinct from both the dominant understanding (i.e. thesis) and alternative perspective (i.e. antithesis) [67] .
Process of Ideation from Innovation DNA
The process of creating commercially viable ideas is achieved by making use of certain skills identified in the innovator's DNA, these skills are as follows:
• Observation;
• Questioning;
• Networking;
• Experimenting;
• Associative thinking. The combination these skills bring about an innovative idea ( Figure 13 ) by making use of the creative skill of an innovator ( Figure 14) .
The compelling need of this thesis is to find if tetracycline can be used to treat mastocytosis. The questions that are asked as follows:
• What is the cause of mastocytosis?
• How can it be treated?
• How can tetracycline help in mastocytosis treatment?
• Is there a possible combination of tetracycline with other compounds to help improve the treatment?
The data used in this research was obtained from various scientifically published materials such as;
• Scientific publications;
• Text books; Figure 13 . Creative synthesis. • Library catalogue;
• Online articles.
The data was selected based on the relevance of the methods that are currently used for the treatment of mast cell diseases and inflammatory related diseases.
Results and Discussion

Chemically Modified Tetracycline
Chemically [69] , although the mechanism as to how they act as apoptotic agents is still not clear.
Mast Cell Stabilizers
Neither ketotifen nor cromolyn are genuine mast cell stabilizers as they don't block inflammatory cytokine discharge. Ketotifen is a histamine-1 receptor enemy that is likewise a weak inhibitor of histamine and prostaglandin discharge through an unknown mechanism. The extra advantage of ketotifen over different antihistamines is that it obstructs the activities of eosinophils generally involved with allergies especially in eosinophilic esophagitis/gastroenteritis. Disodium18 ontelukast18 (cromolyn) was believed to be a "mast cell stabilizer"
since it blocked rat mast cells, however is an extremely weak inhibitor of human mast cells, and like ketotifen, it hinders histamine and prostaglandin discharge to some degree, but not inflammatory cytokine discharge, again through an unknown mechanism.
NeuroProtek contains luteolin and quercetin, both of which have been ap- 
Drugs That Interfere with Mast-Cell Symptoms
There is no treatment that brings about in lasting resolution of the skin sores re- 
Conclusions
When dealing with mastocytosis, there are 4 major problems to put into consideration and should be analyzed, as seen in Figure 15 .
With the use of creative synthesis, an innovative solution has to be created which will have to accomplish a couple of things effectively in order to treat mastocytosis completely and they are as follows in Figure 16 .
The solution will have to be a product that can attack all four of those issues.
The addition of CMT will cause apoptosis of the affected cells, then the addition of and their molecular targets, the genuine capability of any new mast cell stabilizer must be acknowledged once its properties are assessed in an extended scope of preclinical in vitro, ex vivo and in vivo models of efficacy and toxicity [61] .
Potential for CMT's and Polyphenols to Overcome Shortcomings
CMTs are still in their earliest stages with respect to use in humans, for instance, the weaknesses of CMT such as the over the top suppression of MMPs which may disrupt the ordinary physiologic turnover of collagen. The question is would we be able to find the right combination or other dynamic compounds to over- 
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